Log In
Print
BCIQ
Print
Print this Print this
 

CAD106

  Manage Alerts
Collapse Summary General Information
Company Cytos Biotechnology AG
DescriptionVaccine containing beta amyloid 1-6 peptide coupled to the virus-like particle Qb
Molecular Target Beta amyloid
Mechanism of ActionDisrupts amyloid plaques; Vaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat mild to moderate Alzheimer's disease (AD)
Regulatory Designation

Partner

Novartis AG


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today